Gulf International Bank (Uk) LTD Repligen Corp Transaction History

Gulf International Bank (Uk) LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 10, 2024	SELL	$120.0 - $182.95 $21,000 - $32,016	-175 Reduced 3.82%	4,403 $555,000
Q4 2023 Jan 11, 2024	SELL	$114.17 - $185.35 $63,250 - $102,683	-554 Reduced 10.8%	4,578 $823,000
Q3 2023 Oct 10, 2023	SELL	$138.78 - $176.51 $67,863 - $86,313	-489 Reduced 8.7%	5,132 $816,000
Q2 2023 Aug 02, 2023	SELL	$138.42 - $180.31 $222,440 - $289,758	-1,607 Reduced 22.23%	5,621 $795,000
Q1 2023 Apr 12, 2023	SELL	$154.26 - $198.1 $507,052 - $651,154	-3,287 Reduced 31.26%	7,228 $1.22 Million
Q4 2022 Feb 08, 2023	BUY	$162.42 - $220.56 $1.71 Million - $2.32 Million	10,515 New	10,515 $1.78 Million

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Gulf International Bank (Uk) LTD, based on Form 13F filings with the SEC.

Stay updated on Gulf International Bank (Uk) LTD with notifications on news.